Beryl Capital Management’s Urovant Sciences Ltd. UROV Stock Holding History

Beryl Capital Management’s Portfolio UROV Stock Details UROV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-351,579	Closed	-$5.67M	–	386
2020 Q4	$5.67M	Buy	+351,579	New	+$4.36M	0.9%	24

Beryl Capital Management's UROV Position: Q1 2021 in Review

Beryl Capital Management sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 351,579 shares — an estimated $5.67M sold.

Beryl Capital Management first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $5.67M in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

Beryl Capital Management reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
Beryl Capital Management sold 351,579 Urovant Sciences Ltd. shares in Q1 2021, an estimated $5.67M.
Beryl Capital Management first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
Beryl Capital Management's Urovant Sciences Ltd. position peaked at $5.67M in Q4 2020.
0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Beryl Capital Management's 13F filing for Q1 2021, filed 17 May 2021.